We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. The second stock on our list of high growth stocks is UiPath, Inc.
TheFly reported on January 12 that Barclays raised its price target on PATH to $18 from $16 and maintained an Equal Weight rating. As part of its 2026 outlook, the firm revised its software sector ratings and price projections. Barclays noted a favorable background for software, with stable macro conditions and IT spending, appealing stock prices, and sector sentiment staying muted.
Separately, according to reports, on January 15, UiPath, Inc. (NYSE:PATH) saw mixed options activity, with shares down $0.12 near $15.24. Calls were slightly ahead of puts (put/call ratio 0.24), while volume was almost average. The put-call skew increased, indicating a need for downside protection, while implied volatility decreased but remained over the 52-week median.
UiPath, Inc. (NYSE:PATH) is a global software company and leader in agentic automation, providing AI‑enabled robotic process automation (RPA) and workflow orchestration technology that helps enterprises automate complex business processes.
While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.
Disclosure: None.